Supplements · Sweeteners

non-nutritive sweeteners increases diabetes risk

In plain terms: Do artificial sweeteners raise your risk of type 2 diabetes?

Contested Supplements 🔬 Includes disconfirming

RefutedContestedStrong support

consensus score 0.17

Genuinely unsettled. Observational studies often find diet-drink users get more diabetes — but that's badly tangled with reverse causation: people already at risk are the ones who switch to diet drinks. Controlled trials don't show sweeteners causing diabetes. The honest answer is that the studies disagree for a reason.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

4 support 1 contradict 0 tested null 4 mixed · 9 sources, 5 independent groups

What the evidence shows

Artificially-sweetened-beverage consumption is consistently associated with higher type-2-diabetes incidence across large cohorts (and the NutriNet-Santé cohort) — so as an association the claim leans supported.

Cochrane has no ruling yet see how our grade compares ▾

Cochrane review 2020 · very low certainty Not directly comparable

Population is people who ALREADY have type 1 or 2 diabetes, not incident-diabetes risk in the general population.

“Non-nutritive sweeteners for diabetes mellitus (CD012885.pub2). 'There is inconclusive evidence of very low certainty regarding the effects of NNS consumption compared with either sugar, placebo, or nutritive low-calorie sweetener consumption on clinically relevant benefit or harm for HbA1c, body weight, and adverse events in people with type 1 or type 2 diabetes.'”

Not directly comparable: their review asks a different question or reports an outcome we do not grade, so it neither corroborates nor contradicts this claim.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (9)

Source	Grade	Stance	Quality	Finding
Drouin-Chartier et al. 2019 · Diabetes Care	observational	supports	moderate	Three large US cohorts: increases in ASB consumption associated with modestly higher subsequent T2D risk (attenuated by BMI).
Payen de la Garanderie M 2025 · PLoS Med	observational	mixed	moderate	NutriNet-Santé food-additive mixtures (incl. a sweetener/emulsifier cluster) associated with higher T2D incidence.
Qin et al. 2020 · Eur J Epidemiol	meta-analysis	supports	moderate	Dose-response MA: ASB associated with higher T2D (and obesity, hypertension).
Meng 2021 · Nutrients	meta-analysis	supports	moderate	Dose-response MA: each additional ASB serving/day associated with higher T2D risk.
Debras C 2023 · Diabetes Care	observational	supports	high	NutriNet-Santé: total artificial sweeteners (esp. aspartame, acesulfame-K) associated with higher type-2-diabetes risk.
Greenwood et al. 2014 · Br J Nutr	meta-analysis	mixed	moderate	MA: ASB–T2D association less consistent than SSB and attenuated by BMI adjustment — possible confounding/reverse causation.
Imamura et al. 2015 · BMJ	meta-analysis	mixed	high	MA (BMJ): ASB–T2D association substantially attenuated after adjustment for adiposity — largely reflects reverse causation, not a causal effect.
Ayoub-Charette et al. 2025 · Appl Physiol Nutr Metab	meta-analysis	contradicts	high	Bias-adjusted cohort analyses: NNS associated with LOWER obesity/diabetes — the naïve 'higher risk' reverses under substitution/bias-adjusted methods.
Lohner et al. 2020 · Cochrane Database Syst Rev	meta-analysis	mixed	moderate	Cochrane (NNS in diabetes): insufficient evidence to establish benefit or harm on hard outcomes.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.